0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Treatment of severe osteoporosis with alendronate in a patient with lysinuric protein intolerance.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lysinuric protein intolerance is an inborn error of cationic amino acid transport of which osteoporosis is a major feature. Treatment with oral bisphosphonates improves bone mineral density even in severe osteoporosis.

          Related collections

          Author and article information

          Journal
          J Inherit Metab Dis
          Journal of inherited metabolic disease
          Springer Science and Business Media LLC
          0141-8955
          0141-8955
          Oct 2006
          : 29
          : 5
          Affiliations
          [1 ] Unidad de Enfermedades Metabólicas, Hospital Sant Joan de Déu, Barcelona, Spain. lgomez@hsjdbcn.org
          Article
          10.1007/s10545-006-0236-9
          16868861
          18187a30-d010-4e9a-b6e4-4c0836b9c79d
          History

          Comments

          Comment on this article